• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德拉韦综合征:成人神经科医生快速转诊指南

Dravet syndrome: A quick transition guide for the adult neurologist.

作者信息

Andrade Danielle M, Berg Anne T, Hood Veronica, Knupp Kelly G, Koh Sookyong, Laux Linda, Meskis Mary Anne, Miller Ian, Perry M Scott, Scheffer Ingrid E, Sullivan Joseph, Villas Nicole, Wirrell Elaine

机构信息

Adult Epilepsy Genetics Program, Division of Neurology, Krembil Brain Institute, Toronto Western Hospital, University of Toronto, Toronto, Canada.

Ann & Robert H. Lurie Children's Hospital of Chicago, Departments of Pediatrics and Neurological Surgery, Northwestern Feinberg School of Medicine, Chicago, USA.

出版信息

Epilepsy Res. 2021 Nov;177:106743. doi: 10.1016/j.eplepsyres.2021.106743. Epub 2021 Aug 18.

DOI:10.1016/j.eplepsyres.2021.106743
PMID:34624600
Abstract

INTRODUCTION

Dravet syndrome (DS) is still seen as a "pediatric disease", where patients receive excellent care in pediatric centers, but care is less than optimal in adult health care systems (HCS). This creates a barrier when young adults need to leave the family-centered pediatric system and enter the adult, patient-centered HCS. Here we create a guide to help with the transition from pediatric to adult for patients with DS.

METHODS

Experts in Dravet syndrome flagged the main barriers in caring for adults with DS and created a 2-page transition summary guide based on their expertise and a literature review.

RESULTS

The 2-page guide addresses: DS diagnosis in children and adults; clinical manifestations, including the differences in seizures types and frequencies between children and adults with DS; the natural history of intellectual disability, behavior, gait, motor disorders and dysautonomia; a review of optimal treatments (including medications not commonly used in adult epilepsy settings such as stiripentol and fenfluramine), as well as emergency seizure management; avoidance of triggers, preventive measures, and vaccine administration in adults with DS.

CONCLUSION

Several young adults with DS are still followed by their child neurologist. This 2-page transition guide should help facilitate the transition of patients with DS to the adult HCS and should be given to families as well as adult health care providers that may not be familiar with DS.

摘要

引言

德雷维特综合征(DS)仍被视为一种“儿科疾病”,患者在儿科中心能得到优质护理,但在成人医疗保健系统(HCS)中护理则不尽如人意。当年轻人需要离开以家庭为中心的儿科系统,进入以患者为中心的成人HCS时,这就造成了障碍。在此,我们创建了一份指南,以帮助DS患者从儿科过渡到成人阶段。

方法

德雷维特综合征专家指出了护理成年DS患者的主要障碍,并根据他们的专业知识和文献综述创建了一份两页的过渡总结指南。

结果

这份两页的指南涵盖以下内容:儿童和成人DS的诊断;临床表现,包括儿童和成人DS患者癫痫发作类型和频率的差异;智力残疾、行为、步态、运动障碍和自主神经功能障碍的自然病史;最佳治疗方法综述(包括成人癫痫治疗中不常用的药物,如司替戊醇和芬氟拉明),以及癫痫发作的紧急处理;DS成人患者避免触发因素、预防措施和疫苗接种。

结论

仍有几名成年DS患者由他们儿时的神经科医生随访。这份两页的过渡指南应有助于促进DS患者向成人HCS的过渡,应分发给家庭以及可能不熟悉DS的成人医疗保健提供者。

相似文献

1
Dravet syndrome: A quick transition guide for the adult neurologist.德拉韦综合征:成人神经科医生快速转诊指南
Epilepsy Res. 2021 Nov;177:106743. doi: 10.1016/j.eplepsyres.2021.106743. Epub 2021 Aug 18.
2
Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: An indirect treatment comparison.添加抗癫痫药物治疗Dravet综合征的短期疗效和安全性比较:间接治疗比较
Seizure. 2021 Oct;91:316-324. doi: 10.1016/j.seizure.2021.06.020. Epub 2021 Jun 29.
3
Treatment-Refractory Dravet Syndrome: Considerations for Novel Medications.治疗抵抗性 Dravet 综合征:新型药物的考虑因素。
J Pediatr Health Care. 2022 Sep-Oct;36(5):479-488. doi: 10.1016/j.pedhc.2022.05.003.
4
The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.多准则决策分析在西班牙用芬氟拉明治疗德拉韦综合征中的贡献。
Epilepsy Behav. 2022 Jul;132:108711. doi: 10.1016/j.yebeh.2022.108711. Epub 2022 May 16.
5
A critical evaluation of fenfluramine hydrochloride for the treatment of Dravet syndrome.盐酸芬氟拉明治疗德拉韦综合征的评价。
Expert Rev Neurother. 2022 May;22(5):351-364. doi: 10.1080/14737175.2021.1877540. Epub 2021 Feb 26.
6
Improved everyday executive functioning following profound reduction in seizure frequency with fenfluramine: Analysis from a phase 3 long-term extension study in children/young adults with Dravet syndrome.氟苯丙胺可显著降低癫痫发作频率,从而改善日常执行功能:来自 Dravet 综合征儿童/青少年 3 期长期扩展研究的分析。
Epilepsy Behav. 2021 Aug;121(Pt A):108024. doi: 10.1016/j.yebeh.2021.108024. Epub 2021 May 20.
7
Changing Landscape of Dravet Syndrome Management: An Overview.Dravet 综合征管理现状的改变:概述。
Neuropediatrics. 2020 Apr;51(2):135-145. doi: 10.1055/s-0040-1701694. Epub 2020 Feb 20.
8
Treatment with fenfluramine in patients with Dravet syndrome has no long-term effects on weight and growth.使用芬氟拉明治疗 Dravet 综合征患者对体重和生长无长期影响。
Epilepsy Behav. 2021 Sep;122:108212. doi: 10.1016/j.yebeh.2021.108212. Epub 2021 Aug 2.
9
Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients.低剂量芬氟拉明显著降低德雷维特综合征的癫痫发作频率:一项对新患者队列的前瞻性研究。
Eur J Neurol. 2017 Feb;24(2):309-314. doi: 10.1111/ene.13195. Epub 2016 Oct 28.
10
Pharmacotherapy for Dravet Syndrome.用于治疗德雷维特综合征的药物疗法。
Paediatr Drugs. 2016 Jun;18(3):197-208. doi: 10.1007/s40272-016-0171-7.

引用本文的文献

1
Nonseizure Outcomes in Dravet Syndrome: Potential Impact of Pharmacotherapy.德雷维特综合征的非癫痫发作结局:药物治疗的潜在影响。
CNS Drugs. 2025 Aug 21. doi: 10.1007/s40263-025-01212-5.
2
Advancements in Dravet Syndrome Therapeutics: A Comprehensive Look at Present and Future Treatment Horizons: A Focused Review.德雷维特综合征治疗进展:全面审视当前与未来的治疗前景:一篇聚焦综述
Ann Indian Acad Neurol. 2024 Jul 1;27(4):352-357. doi: 10.4103/aian.aian_49_24. Epub 2024 Aug 16.
3
Navigating Dravet syndrome in Spain: A cross-sectional study of diagnosis, management, and care coordination.
西班牙德拉韦特综合征诊疗现状:一项关于诊断、治疗和医疗协调的横断面研究。
Epilepsia Open. 2024 Oct;9(5):1806-1815. doi: 10.1002/epi4.13012. Epub 2024 Jul 10.
4
Clinical and Genetic Features of Dravet Syndrome: A Prime Example of the Role of Precision Medicine in Genetic Epilepsy.德拉维特综合征的临床和遗传特征:精准医学在遗传性癫痫中的作用的典型范例。
Int J Mol Sci. 2023 Dec 19;25(1):31. doi: 10.3390/ijms25010031.
5
Neuromuscular disorders and transition from pediatric to adult care in a multidisciplinary perspective: a narrative review of the scientific evidence and current debate.神经肌肉疾病及多学科视角下的儿科至成人医疗过渡:对科学证据和当前争议的叙述性综述。
Acta Myol. 2022 Dec 31;41(4):188-200. doi: 10.36185/2532-1900-083. eCollection 2022.
6
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.抗癫痫药物治疗发育性和癫痫性脑病的精神行为和认知不良事件。
CNS Drugs. 2022 Oct;36(10):1079-1111. doi: 10.1007/s40263-022-00955-9. Epub 2022 Oct 4.
7
Opportunities for Community Pharmacists to Counsel Patients With Epilepsy and Seizure Clusters to Overcome Barriers and Foster Appropriate Treatment.社区药师为癫痫和发作群患者提供咨询的机会,以克服障碍并促进适当的治疗。
J Pharm Pract. 2024 Feb;37(1):190-197. doi: 10.1177/08971900221126570. Epub 2022 Oct 4.
8
International consensus on diagnosis and management of Dravet syndrome.国际 Dravet 综合征诊断与管理共识。
Epilepsia. 2022 Jul;63(7):1761-1777. doi: 10.1111/epi.17274. Epub 2022 May 12.
9
COVID-19 vaccine in patients with Dravet syndrome: Observations and real-world experiences.Dravet 综合征患者的 COVID-19 疫苗:观察结果和真实世界经验。
Epilepsia. 2022 Jul;63(7):1778-1786. doi: 10.1111/epi.17250. Epub 2022 Apr 20.